21 02, 2017

#AGBT17

By | February 21st, 2017|Categories: Conferences, Next-generation sequencing, Single-cell sequencing|0 Comments

This years #AGBT17 did not look as exciting as previous years have done, especially with all the major announcements being made at JP Morgan. In fact Illumina even went as far as to say they’d have no news at all during the conference! However there was […]

15 02, 2017

Nanostring Hyb&Seq

By | February 15th, 2017|Categories: Conferences, Methods and applications, Next-generation sequencing, Other stuff|Tags: , , |4 Comments

Nanostring had an interesting poster presented by Joe Beecham at last years AGBT describing their novel single-molecule hybridization-based sequencing chemistry (see AGBT and JPMorgan 2016 coverage from GenomeWeb). This utilizes the Nanostring optical barcodes in a new configuration to deliver Hyb&Seq: no amplification, no enzymes, and no […]

16 09, 2016

Reporting on Fluidigm’s single-cell user meeting at the Sanger Institute

By | September 16th, 2016|Categories: Conferences, Next-generation sequencing, Single-cell sequencing|0 Comments

The Genomics community is pushing ahead fast on single-cell analysis methods as these are revolutionising how we approach biological questions. Unfortunately my registration went in too late for the meeting running at the Sanger Institute this week (Follow #SCG16 on Twitter), but the Fluidigm pre-meeting was a […]

3 11, 2012

Session 4: Functional genomics of cancer

By | November 3rd, 2012|Categories: Conferences|0 Comments

Go back to the summary of the CRI symposium.Carlos Caldas, Functional genomics of cancer: perturbation experiments in the lab and in the clinic. Carlos is a senior group leader at the Cancer Research UK Cambridge Research Institute where I work, he is also a practising […]

3 11, 2012

Session 1: Cancer genome sequencing

By | November 3rd, 2012|Categories: Conferences|1 Comment

Go back to the summary of the CRI symposium.Overall summary: The top10 BrCA CaGens only account for 50% of mutation load, the tail is going to be important in personalising treatment. Some patients  only show a single driver mutation, can cancer be driven by a […]

Load More Posts